Serum prolactin levels in Behcet's disease

被引:9
|
作者
Apaydin, KC
Duranoglu, Y
Özgürel, Y
Saka, O
机构
[1] Akdeniz Univ, Fac Med, Dept Ophthalmol, Antalya, Turkey
[2] Antalya State Hosp, Antalya, Turkey
[3] Akdeniz Univ, Fac Med, Dept Biostat, Antalya, Turkey
关键词
Behcet's disease; prolactin; radioimmunoassay;
D O I
10.1016/S0021-5155(00)00171-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Evaluation of serum prolactin levels in Behcet's disease patients in Turkey. Methods: Serum prolactin levels were measured by radio-immunoassay (RIA) in 17 patients with ocular findings, and 20 patients without ocular findings of Behcet's disease, and in 17 healthy volunteers. Results: The average prolactin levers were measured as 9.53 ng/mL in patients with ocular findings, 8.84 ng/mL in patients without ocular findings, and 9.59 ng/mL in healthy controls. There was no statistical significance among these three groups. Also, the average levels were 9.84 ng/mL in remission periods and 7.54 ng/mL in attacks. Conclusions: In some studies, it has been suggested there is a correlation between high serum prolactin levels and activation of some autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. However, we found no such correlation in Behcet's disease. On the contrary, prolactin levels were lower in attacks than in remissions. (C) 2000 Japanese Ophthalmological Society.
引用
收藏
页码:442 / 445
页数:4
相关论文
共 50 条
  • [41] Vascular endothelial growth factor gene polymorphisms and serum levels in Behcet's disease
    Kamoun, M.
    Houman, M. H.
    Hamzaoui, A.
    Hamzaoui, K.
    TISSUE ANTIGENS, 2008, 72 (06): : 581 - 587
  • [42] Leptin Levels in Patients with Behcet's Disease
    Inanir, Isil
    Gunduz, Kamer
    Onur, Ece
    Pirildar, Timur
    Var, Ahmet
    Olcer, Nesrin
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (04): : 209 - 212
  • [43] Nitric oxide levels in Behcet's disease
    Sancak, B
    Önder, M
    Öztas, MO
    Bukan, N
    Gürer, MA
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (01) : 7 - 9
  • [44] An Evaluation of Hormone Levels in Behcet's Disease
    Karakus, Sema
    Nar, Asli
    Toprak, Selami Kocak
    Atalay, Figen
    Ozcebe, Osman Ilhami
    TURKISH JOURNAL OF RHEUMATOLOGY, 2012, 27 (03) : 158 - 164
  • [45] Serum mannose-binding lectin levels are decreased in Behcet's disease and associated with disease severity
    Inanc, N
    Mumcu, G
    Birtas, E
    Elbir, Y
    Yavuz, S
    Ergun, T
    Fresko, I
    Direskeneli, H
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (02) : 287 - 291
  • [46] Serum YKL-40 and MDA levels in Behcet disease
    Bilen, Handan
    Altinkaynak, Konca
    Sebin, Engin
    Aksoy, Hulya
    Akcay, Fatih
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2016, 66 (10) : 1299 - 1302
  • [47] Is there any relationship between serum and urine neopterin and serum interferon-γ levels in the activity of Behcet's disease?
    Erturan, I.
    Basak, P. Y.
    Ozturk, O.
    Ceyhan, A. M.
    Akkaya, V. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (12) : 1414 - 1418
  • [48] Evaluation of serum resistin levels in patients with ocular and non-ocular Behcet's disease
    Yalcindag, F. Niluefer
    Yalcindag, Ali
    Batioglu, Figen
    Caglayan, Osman
    Kisa, Ucler
    Ozdemir, Ozden
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2008, 43 (04): : 473 - 475
  • [49] IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features
    Zarrabi, Maryam
    Gholijani, Nasser
    Shenavandeh, Saeedeh
    Aflaki, Elham
    Amirghofran, Zahra
    EUROPEAN CYTOKINE NETWORK, 2019, 30 (03) : 82 - 87
  • [50] Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behcet's disease
    Wakiya, Risa
    Ushio, Yusuke
    Ueeda, Kiyo
    Kameda, Tomohiro
    Shimada, Hiromi
    Nakashima, Shusaku
    Kato, Mikiya
    Miyagi, Taichi
    Sugihara, Koichi
    Mizusaki, Mao
    Mino, Rina
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    DERMATOLOGIC THERAPY, 2022, 35 (08)